Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Eli Lilly a Buy?
Motley Fool
Monday, June 28, 2010 - 6:59pm
tags:
Eli Lilly
Merck Loses $8 Million Verdict in Trial Over Fosamax
Bloomberg Businessweek
Monday, June 28, 2010 - 3:05pm
tags:
Merck, Fosamax, osteoporosis, lawsuits
There Is Such a Thing as a Free Lunch, and Massachusetts Wants to Make It Law
BNET Pharma
Monday, June 28, 2010 - 3:01pm
tags:
physicians, physician gifts, Massachusetts
Dendreon’s Provenge Vaccine Faces Rationing
Pharmalot
Monday, June 28, 2010 - 3:00pm
tags:
Dendreon, Provenge, vaccines, prostate cancer
Amylin's New Diabetes Drug Well Tolerated By Sufferers
CNBC
Monday, June 28, 2010 - 2:59pm
tags:
Amylin, diabetes, Bydureon, type 2 diabetes
Exelixis: Finding Opportunity in a Bottomed Stock
Seeking Alpha
Monday, June 28, 2010 - 2:58pm
tags:
Exelixis, Bristol-Myers Squibb, cancer
The Sky's the Limit for Avanir Pharmaceuticals
Seeking Alpha
Monday, June 28, 2010 - 2:56pm
tags:
Avanir, Zenvia
Orexigen says obesity drug treated depression
Yahoo/AP
Monday, June 28, 2010 - 2:55pm
tags:
Orexigen, obesity, depression, Contrave
Biodel, Arena Pharma: Volume Movers
TheStreet.com
Monday, June 28, 2010 - 2:54pm
tags:
Biodel, Arena Pharmaceuticals, diabetes, obesity
Mannkind Falls Following Afrezza Presentation; Hapoalim Reiterates Sell
Barron's
Monday, June 28, 2010 - 2:53pm
tags:
MannKind, Afrezza, diabetes, inhaled insulin, Hapoalim
Novartis needs Alcon directors' OK for buyout -advisor
Reuters
Monday, June 28, 2010 - 1:45pm
tags:
Alcon, M&A, Novartis
Avandia, Heart Attacks & An Upcoming FDA Meeting
Pharmalot
Monday, June 28, 2010 - 1:43pm
tags:
Avandia, heart attacks, GSK, diabetes, FDA, Actos, Takeda
Data shows declining productivity in drug R&D
Reuters
Monday, June 28, 2010 - 1:42pm
tags:
R&D, drug development
Good News for Shire
Yahoo/Zacks.com
Monday, June 28, 2010 - 1:39pm
tags:
Shire, Pfizer, Protalix BioTherapeutics, Vpriv, Gaucher disease
Marcadia and Lilly Sign Development, License Agreement for Novel Glucagon Program in Severe Hypoglycemia
Yahoo
Monday, June 28, 2010 - 1:36pm
tags:
Eli Lilly, Marcadia, hypoglycemia, partnerships, glucagon
Doc Who Faked Pfizer Studies Gets 6 Months in Prison, Showing Why Gift Bans Are a Good Idea
BNET Pharma
Monday, June 28, 2010 - 1:31pm
tags:
physician gifts, Pfizer
Astellas Pharma, Teva Reach Settlement Over Incontinence Medicine Vesicare
Bloomberg
Monday, June 28, 2010 - 9:58am
tags:
Astellas, Teva Pharmaceuticals, settlements, Vesicare, urinary incontinence
J&J Subsidiary Joins the Diabetes Fray
Seeking Alpha
Monday, June 28, 2010 - 9:56am
tags:
diabetes, JNJ, Ortho-McNeil-Janssen, Metabolex, Diamyd Medical
5 Reasons Why Amarin Is My Top Buy
Seeking Alpha
Sunday, June 27, 2010 - 11:23am
tags:
Amarin, Epadel, GSK, Lovaza, omega-3 fatty acid, AMR101
Editorials: In praise of an unsinkable biotech business
Mlive
Sunday, June 27, 2010 - 11:18am
tags:
Esperion Therapeutics, HDL therapy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.